X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (313) 313
diminazene - therapeutic use (264) 264
diminazene - analogs & derivatives (221) 221
trypanocidal agents - therapeutic use (154) 154
female (133) 133
trypanosomiasis, african - drug therapy (133) 133
male (127) 127
mice (118) 118
cattle (110) 110
parasitology (102) 102
index medicus (89) 89
trypanosomiasis, african - veterinary (89) 89
diminazene - pharmacology (88) 88
veterinary sciences (82) 82
antiprotozoal agents - therapeutic use (57) 57
drug resistance (55) 55
diminazene aceturate (53) 53
trypanosomiasis, bovine - drug therapy (51) 51
phenanthridines - therapeutic use (50) 50
trypanosomiasis, african - parasitology (46) 46
tropical medicine (45) 45
trypanocidal agents - pharmacology (44) 44
diminazene (43) 43
rats (43) 43
trypanosomiasis - drug therapy (43) 43
amidines - therapeutic use (41) 41
babesiosis - drug therapy (38) 38
african trypanosomiasis (34) 34
dogs (34) 34
humans (31) 31
trypanosoma brucei brucei (31) 31
trypanosoma congolense (30) 30
trypanosomiasis, african - immunology (30) 30
diminazene - administration & dosage (29) 29
time factors (29) 29
chemotherapy (28) 28
trypanosoma congolense - drug effects (27) 27
disease models, animal (26) 26
trypanosoma - drug effects (26) 26
dose-response relationship, drug (25) 25
trypanosoma brucei brucei - drug effects (25) 25
isometamidium chloride (24) 24
phenanthridines - pharmacology (24) 24
recurrence (24) 24
veterinary medicine (24) 24
trypanosomiasis, african - epidemiology (23) 23
dog diseases - drug therapy (22) 22
drug therapy, combination (22) 22
goats (22) 22
hematocrit - veterinary (22) 22
infections (22) 22
diagnosis (21) 21
horses (21) 21
infection (21) 21
trypanocidal agents - administration & dosage (21) 21
trypanosomiasis (21) 21
trypanosomiasis - veterinary (21) 21
trypanosomiasis, african - prevention & control (21) 21
trypanosomiasis, bovine - parasitology (21) 21
congolense (20) 20
pharmacology & pharmacy (19) 19
trypanosomiasis, bovine - epidemiology (19) 19
isometamidium (18) 18
parasitemia - drug therapy (18) 18
berenil (17) 17
brucei (17) 17
trypanosomiasis, bovine - prevention & control (17) 17
mice, inbred balb c (16) 16
parasitemia (16) 16
parasitic diseases (16) 16
research article (16) 16
tsetse flies (16) 16
tsetse flies - parasitology (16) 16
analysis (15) 15
ethidium - therapeutic use (15) 15
health aspects (15) 15
parasitemia - veterinary (15) 15
parasites (15) 15
drug-resistance (14) 14
hematocrit (14) 14
suramin - therapeutic use (14) 14
trypanosoma brucei (14) 14
trypanosoma evansi (14) 14
trypanosomiasis - parasitology (14) 14
trypanosomiasis, bovine - immunology (14) 14
expression (13) 13
kenya (13) 13
peptidyl-dipeptidase a - metabolism (13) 13
random allocation (13) 13
sheep (13) 13
trypanosoma congolense - immunology (13) 13
trypanosomosis (13) 13
zoology (13) 13
babesiosis - veterinary (12) 12
bovine trypanosomiasis (12) 12
dna (12) 12
vivax (12) 12
antibodies, protozoan - blood (11) 11
antiprotozoal agents - pharmacology (11) 11
arsenicals - therapeutic use (11) 11
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Parasites and Vectors, ISSN 1756-3305, 01/2019, Volume 12, Issue 1, pp. 37 - 37
Journal Article
Neuropharmacology, ISSN 0028-3908, 05/2018, Volume 133, pp. 85 - 93
This study used mice to evaluate whether coupling expression of corticotropin-releasing hormone (CRH) and angiotensin converting enzyme 2 (ACE2) creates... 
CRH | HPA | PVN | Anxiety | Corticosterone | Stress | HPA AXIS ACTIVITY | DIMINAZENE ACETURATE | 1A RECEPTORS | ANXIETY-LIKE BEHAVIOR | NEUROSCIENCES | FACTOR-LIKE IMMUNOREACTIVITY | PARAVENTRICULAR NUCLEUS | DISORDER | PHARMACOLOGY & PHARMACY | PITUITARY-ADRENAL RESPONSE | HYPERTENSION | BRAIN | Pituitary Gland - metabolism | Enzyme Activators - therapeutic use | Injections, Intraventricular | Adrenocorticotropic Hormone - pharmacology | Male | Anxiety - drug therapy | RNA, Messenger - metabolism | Dose-Response Relationship, Drug | Peptidyl-Dipeptidase A - genetics | Stress, Psychological - metabolism | Corticotropin-Releasing Hormone - therapeutic use | Peptidyl-Dipeptidase A - metabolism | Corticotropin-Releasing Hormone - genetics | Pro-Opiomelanocortin - genetics | Disease Models, Animal | Pituitary-Adrenal System - diagnostic imaging | Hormones - pharmacology | Hypothalamo-Hypophyseal System - drug effects | Pituitary-Adrenal System - metabolism | Stress, Psychological - drug therapy | Mice, Inbred C57BL | Corticotropin-Releasing Hormone - blood | Diminazene - analogs & derivatives | Maze Learning - drug effects | Corticotropin-Releasing Hormone - metabolism | Hypothalamo-Hypophyseal System - metabolism | Mice, Knockout | Pro-Opiomelanocortin - metabolism | Stress, Psychological - genetics | Animals | Mice | Anxiety - etiology | Diminazene - therapeutic use | stress | anxiety | corticosterone
Journal Article
Journal Article
Journal Article
Experimental Parasitology, ISSN 0014-4894, 02/2015, Volume 149, pp. 39 - 46
Journal Article
Hypertension, ISSN 0194-911X, 07/2015, Volume 66, Issue 1, pp. 141 - 148
The angiotensin-converting enzyme 2/angiotensin-(1–7)/Mas axis represents a promising target for inducing stroke neuroprotection. Here, we explored... 
angiotensin converting enzyme 2 | stroke | MECHANISM | RECEPTOR | ENDOTHELIAL PROGENITOR CELLS | ACE2 | IN-VITRO | PATHWAY | PROTECTS BRAIN | PERIPHERAL VASCULAR DISEASE | EXPRESSION | CONTRIBUTES | AXIS | ADAM17 Protein | Neuroprotective Agents - therapeutic use | Infarction, Middle Cerebral Artery - physiopathology | Leucine - pharmacology | Leucine - toxicity | Male | Peptide Fragments - pharmacology | Peptidyl-Dipeptidase A - physiology | ADAM Proteins - biosynthesis | RNA, Messenger - biosynthesis | Neuroprotective Agents - pharmacology | Peptidyl-Dipeptidase A - blood | Infarction, Middle Cerebral Artery - complications | Imidazoles - toxicity | Infarction, Middle Cerebral Artery - drug therapy | Receptors, G-Protein-Coupled - drug effects | Corpus Striatum - enzymology | Leucine - analogs & derivatives | Cerebral Infarction - pathology | Disease Models, Animal | Receptors, G-Protein-Coupled - physiology | Diminazene - pharmacology | Angiotensin II - pharmacology | Cerebral Cortex - enzymology | Proto-Oncogene Proteins - drug effects | Cerebrovascular Circulation - drug effects | Rats | Renin-Angiotensin System - genetics | Imidazoles - pharmacology | Peptidyl-Dipeptidase A - analysis | Angiotensin II - analogs & derivatives | Diminazene - analogs & derivatives | Random Allocation | Enzyme Activation - drug effects | Rats, Sprague-Dawley | Animals | Endothelin-1 | Proto-Oncogene Proteins - physiology | Cerebral Infarction - etiology | Renin-Angiotensin System - drug effects | ADAM Proteins - genetics | Infarction, Middle Cerebral Artery - enzymology | Infusions, Intraventricular | Diminazene - therapeutic use | Neuroprotection | Stroke | tumor necrosis factor-α-converting enzyme (TACE or ADAM17) | Angiotensin-(1-7) | Angiotensin Converting Enzyme 2 | Renin-angiotensin system | Mas
Journal Article
BMC Veterinary Research, ISSN 1746-6148, 11/2018, Volume 14, Issue 1, pp. 361 - 8
Journal Article
Journal Article